236 related articles for article (PubMed ID: 29401357)
1. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis.
Rezk T; Gilbertson JA; Rowczenio D; Bass P; Lachmann HJ; Wechalekar AD; Fontana M; Mahmood S; Sachchithanantham S; Whelan CJ; Wong J; Rendell N; Taylor GW; Hawkins PN; Gillmore JD
Nephrol Dial Transplant; 2018 Feb; 33(2):241-247. PubMed ID: 29401357
[TBL] [Abstract][Full Text] [Related]
2. Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients.
Li DY; Liu D; Wang SX; Yu XJ; Cui Z; Zhou FD; Zhao MH
Amyloid; 2020 Jun; 27(2):134-141. PubMed ID: 32024381
[No Abstract] [Full Text] [Related]
3. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis.
Said SM; Sethi S; Valeri AM; Chang A; Nast CC; Krahl L; Molloy P; Barry M; Fidler ME; Cornell LD; Leung N; Vrana JA; Theis JD; Dogan A; Nasr SH
Kidney Int; 2014 Aug; 86(2):370-7. PubMed ID: 24451324
[TBL] [Abstract][Full Text] [Related]
4. De novo leukocyte chemotactic factor 2 amyloidosis in a pediatric renal allograft, 15 years post-transplant.
Shamir ER; Lee MM; Walavalkar V
Pediatr Transplant; 2019 May; 23(3):e13371. PubMed ID: 30714275
[TBL] [Abstract][Full Text] [Related]
5. Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis.
Chandan VS; Shah SS; Lam-Himlin DM; Petris GD; Mereuta OM; Dogan A; Torbenson MS; Wu TT
Am J Surg Pathol; 2015 Apr; 39(4):558-64. PubMed ID: 25602789
[TBL] [Abstract][Full Text] [Related]
6. Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis.
Law S; Gillmore J; Gilbertson JA; Bass P; Salama AD
BMC Nephrol; 2020 Feb; 21(1):74. PubMed ID: 32111193
[TBL] [Abstract][Full Text] [Related]
7. Clinically occult amyloidosis derived from leukocyte chemotactic factor 2 (ALECT 2) with cardiac involvement complicating renal transplantation: case report and literature review.
Eletta O; Ali M; Grieff A; Puri S; Matsuda K; Bongu A; Fyfe B
Cardiovasc Pathol; 2021; 55():107375. PubMed ID: 34371188
[TBL] [Abstract][Full Text] [Related]
8. LECT-2 amyloidosis: what do we know?
Mann BK; Bhandohal JS; Cobos E; Chitturi C; Eppanapally S
J Investig Med; 2022 Feb; 70(2):348-353. PubMed ID: 34848562
[TBL] [Abstract][Full Text] [Related]
9. Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis.
Larsen CP; Kossmann RJ; Beggs ML; Solomon A; Walker PD
Kidney Int; 2014 Aug; 86(2):378-82. PubMed ID: 24522497
[TBL] [Abstract][Full Text] [Related]
10. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
[TBL] [Abstract][Full Text] [Related]
11. [Leukocyte chemotactic factor 2 associated renal amyloidosis: one case report].
Wang Y; Wang SX; Zhang YK
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 47(2):349-51. PubMed ID: 25882959
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians.
Larsen CP; Ismail W; Kurtin PJ; Vrana JA; Dasari S; Nasr SH
Mod Pathol; 2016 Apr; 29(4):416-20. PubMed ID: 26867784
[TBL] [Abstract][Full Text] [Related]
13. ALECT2 amyloidosis: a new type of systemic amyloid highly prevalent in the Hispanic population.
Jiménez-Zepeda VH; Leung N
Rev Invest Clin; 2014; 66(3):269-73. PubMed ID: 25695244
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte Cell-Derived Chemotaxin-2 Amyloidosis (ALECT2) in a Patient With Lung Adenocarcinoma: An Autopsy Report and Literature Review.
Tariq H; Sharkey FE
Int J Surg Pathol; 2018 May; 26(3):271-275. PubMed ID: 29017384
[TBL] [Abstract][Full Text] [Related]
15. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
16. AA amyloidosis complicating the hereditary periodic fever syndromes.
Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
[TBL] [Abstract][Full Text] [Related]
17. Cryo-EM structure of a human LECT2 amyloid fibril reveals a network of polar ladders at its core.
Richards LS; Flores MD; Zink S; Schibrowsky NA; Sawaya MR; Rodriguez JA
Structure; 2023 Nov; 31(11):1386-1393.e3. PubMed ID: 37657439
[TBL] [Abstract][Full Text] [Related]
18. Concurrence of leukocyte chemotactic factor 2-associated amyloidosis and autoimmune diseases: A case report.
Wang S; Yu XJ; Li DY; Xu J; Wang SX
Front Immunol; 2022; 13():966591. PubMed ID: 36059556
[TBL] [Abstract][Full Text] [Related]
19. Systemic AA amyloidosis.
Pinney JH; Lachmann HJ
Subcell Biochem; 2012; 65():541-64. PubMed ID: 23225016
[TBL] [Abstract][Full Text] [Related]
20. Pathology and diagnosis of renal non-AL amyloidosis.
Sethi S; Theis JD
J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
